Position in BCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$388,230
-$30,926 QoQ
Shares Held
38,823
-11.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#174
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $31,211,469 across 27 Drug Manufacturers - Specialty & Generic names. BCRX ranks #15 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
109,096 | $7,839,638 | |
| 2 | PRGO |
PERRIGO Co plc
|
632,256 | $6,569,139 | |
| 3 | VTRS |
Viatris Inc
|
236,959 | $3,762,908 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
3,067 | $1,661,792 | |
| 5 | ALKS |
Alkermes plc.
|
29,373 | $1,539,145 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
37,512 | $1,300,541 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
11,126 | $1,234,318 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
7,264 | $1,224,274 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $388,230 | 38,823 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $419,156 | 44,029 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $371,311 | 47,604 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $328,624 | 43,297 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $454,675 | 50,745 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $406,185 | 54,158 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $511,390 | 68,004 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $389,667 | 51,272 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $235,631 | 38,128 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $246,395 | 48,503 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $266,327 | 44,462 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $262,044 | 37,012 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $259,621 | 36,878 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $291,040 | 34,897 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $450,991 | 39,285 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $454,645 | 36,083 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $373,399 | 35,293 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $859,649 | 52,869 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $894,336 | 64,573 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $876,541 | 60,998 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,234,033 | 78,054 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $728,924 | 71,674 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $494,531 | 66,380 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $172,368 | 50,107 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $231,426 | 48,619 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $60,410 | 30,205 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||